Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Rate of change in carotid intima-media thickness and vascular events: meta-analyses can not solve all the issues. A point of view.

Bots ML, Taylor AJ, Kastelein JJ, Peters SA, den Ruijter HM, Tegeler CH, Baldassarre D, Stein JH, O'Leary DH, Revkin JH, Grobbee DE.

J Hypertens. 2012 Sep;30(9):1690-6.

PMID:
22895014
2.

Effects of torcetrapib in patients at high risk for coronary events.

Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B; ILLUMINATE Investigators.

N Engl J Med. 2007 Nov 22;357(21):2109-22. Epub 2007 Nov 5.

3.

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Bots ML, Visseren FL, Evans GW, Riley WA, Revkin JH, Tegeler CH, Shear CL, Duggan WT, Vicari RM, Grobbee DE, Kastelein JJ; RADIANCE 2 Investigators.

Lancet. 2007 Jul 14;370(9582):153-160. doi: 10.1016/S0140-6736(07)61088-5.

PMID:
17630038
4.

Designs of RADIANCE 1 and 2: carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis.

Kastelein JJ, van Leuven SI, Evans GW, Riley WA, Revkin JH, Shear CL, Bots ML; RADIANCE 1 and 2 Study Investigators.

Curr Med Res Opin. 2007 Apr;23(4):885-94.

PMID:
17407645
5.

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.

Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML; RADIANCE 1 Investigators.

N Engl J Med. 2007 Apr 19;356(16):1620-30. Epub 2007 Mar 26.

6.

Effect of torcetrapib on the progression of coronary atherosclerosis.

Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM; ILLUSTRATE Investigators.

N Engl J Med. 2007 Mar 29;356(13):1304-16. Epub 2007 Mar 26. Erratum in: N Engl J Med. 2007 Aug 23;357(8):835. Lasala, Gregory P [corrected to Lasala, Gabriel P].

7.

Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future.

Revkin JH, Shear CL, Pouleur HG, Ryder SW, Orloff DG.

Pharmacol Rev. 2007 Mar;59(1):40-53. Review.

PMID:
17329547
10.

Cardiac endothelial transport and metabolism of adenosine and inosine.

Schwartz LM, Bukowski TR, Revkin JH, Bassingthwaighte JB.

Am J Physiol. 1999 Sep;277(3):H1241-51. doi: 10.1152/ajpheart.1999.277.3.H1241.

11.

A collaborative project in Connecticut to improve the care of patients with acute myocardial infarction.

Meehan TP, Radford MJ, Vaccarino LV, Gottlieb LD, McGovern-Hughes B, Herman MV, Revkin JH, Therrien ML, Petrillo MK, Krumholz HM.

Conn Med. 1997 Mar;61(3):147-55.

PMID:
9097486
12.

A collaborative project in Connecticut to improve the care of patients with acute myocardial infarction.

Meehan TP, Radford MJ, Vaccarino LV, Gottlieb LD, McGovern-Hughes B, Herman MV, Revkin JH, Therrien ML, Petrillo MK, Krumholz HM.

Jt Comm J Qual Improv. 1996 Nov;22(11):751-61.

PMID:
8937949
13.

Optimal timing and indications for cholecystectomy in cardiac transplant patients.

Begos DG, Franco KL, Baldwin JC, Lee FA, Revkin JH, Modlin IM.

World J Surg. 1995 Jul-Aug;19(4):661-7. Review.

PMID:
7676717
14.

Effect of insulin on rat heart and skeletal muscle phenylalanyl-tRNA labeling and protein synthesis in vivo.

Young LH, Stirewalt W, McNulty PH, Revkin JH, Barrett EJ.

Am J Physiol. 1994 Aug;267(2 Pt 1):E337-42.

PMID:
8074214
15.

Triple-label beta liquid scintillation counting.

Bukowski TR, Moffett TC, Revkin JH, Ploger JD, Bassingthwaighte JB.

Anal Biochem. 1992 Jul;204(1):171-80.

16.

Limited cytomegalovirus-specific immunoglobulin M and immunoglobulin G profiles in heart transplant recipients.

Allen MD, Denny CF, Kruse AP, Revkin JH, Fishbein DP, Ashley RL.

J Heart Lung Transplant. 1991 Sep-Oct;10(5 Pt 1):664-73.

PMID:
1659902
17.

In vivo measurement of myocardial protein turnover using an indicator dilution technique.

Revkin JH, Young LH, Stirewalt WS, Dahl DM, Gelfand RA, Zaret BL, Barrett EJ.

Circ Res. 1990 Oct;67(4):902-12.

PMID:
2208613
18.

Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty.

Young LH, Jaffe CC, Revkin JH, McNulty PH, Cleman M.

Am J Cardiol. 1990 Apr 15;65(15):986-90. Erratum in: Am J Cardiol 1990 Sep 15;66(7):772.

PMID:
2327360
19.

An isotopic method for measurement of muscle protein synthesis and degradation in vivo.

Barrett EJ, Revkin JH, Young LH, Zaret BL, Jacob R, Gelfand RA.

Biochem J. 1987 Jul 1;245(1):223-8.

Supplemental Content

Loading ...
Support Center